Hester Bios

{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,638.00",
    "chg": -20.2,
    "chgp": "-1.22%",
    "dir": -1,
    "prev_price": "1,658.20",
    "mcapval": "1,416.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "May 07",
    "curr_time": "",
    "bse_nse_vol": "4.99 k",
    "exc_status": "Active",
    "traded_date": "May 07, 2026",
    "traded_date_str": "2026 05 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-3973001",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_mojoScore_3973001.png",
        "date": "2026-05-03 10:10:02",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-comparisons-3963490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_valuationdot_3963490.png",
        "date": "2026-04-27 08:00:18",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift markedly, moving from expensive to very expensive territory. Despite a modest day gain of 1.27%, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Hester Biosciences Gains 0.35%: 3 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-gains-035-3-key-factors-driving-the-weeks-mixed-momentum-3962957",
        "imagepath": "",
        "date": "2026-04-26 09:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Stock opens at Rs.1,477.25, down 1.04% amid weak market sentiment</p>\n                    <p><strong>21 Apr:</strong> Technical momentum shifts amid bearish signals; valuation shifts to “expensive” rating</p>\n                    <p><strong>22 Apr:</strong> Technical momentum shows mild improvement but remains cautious</p>\n                    <p><strong>24 Apr:</strong> Stock closes the week at Rs.1,498.00, up 1.27% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,492.80</div></div>\n                    <div class=\"stat-item\"><..."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-3956735",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_mojoScore_3956735.png",
        "date": "2026-04-22 10:10:03",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3956698",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_technicaldot_3956698.png",
        "date": "2026-04-22 08:01:07",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 0.25%, the stock’s technical indicators present a complex picture, with weekly signals showing mild bullish tendencies contrasting with monthly bearish trends. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity amid mixed signals."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-bearish-signals-3954920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_technicaldot_3954920.png",
        "date": "2026-04-21 08:01:42",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish stance. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum and trend indicators signal weakening price strength."
      },
      {
        "title": "Hester Biosciences Ltd: Valuation Shifts Signal Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-valuation-shifts-signal-price-attractiveness-amid-sector-challenges-3954800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_valuationdot_3954800.png",
        "date": "2026-04-21 08:00:21",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions of the stock’s price attractiveness amid fluctuating financial metrics and sector comparisons."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-3942457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_mojoScore_3942457.png",
        "date": "2026-04-11 10:10:25",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Markets Rally, But Hester Biosciences Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-stock-hits-52-week-low-at-rs125095-3928437",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_priceRelatedfactors_3928437.png",
        "date": "2026-04-01 09:53:00",
        "description": "Despite a broadly positive market environment, Hester Biosciences Ltd has fallen to a fresh 52-week low of Rs 1,250.95 on 1 Apr 2026, marking a 10.27% decline over the past year and underperforming the Sensex by a wide margin."
      }
    ],
    "total": 5454,
    "sid": "324228",
    "stock_news_url": "https://www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "details": "Hester Biosciences Limited has informed the Exchange regarding Board meeting held on November 06, 2019.",
      "source": "NSE",
      "caption": "Hester Biosciences Limited - Outcome of Board Meeting",
      "datetime": "06-Nov-2019"
    },
    {
      "details": "Hester Biosciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Hester Biosciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "31-Oct-2019"
    },
    {
      "details": " <table><tr><td>There is Discrepancies in earlier filed Voting Results. So we have rectified the error and uploaded revised file. </td></tr></table>",
      "source": "NSE",
      "caption": "Shareholders meeting",
      "datetime": "05-Aug-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>70%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Ltd is Rated Sell

2026-05-03 10:10:02

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Hester Biosciences Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons

2026-04-27 08:00:18

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift markedly, moving from expensive to very expensive territory. Despite a modest day gain of 1.27%, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to peers and historical benchmarks.

Read full news article

Hester Biosciences Gains 0.35%: 3 Key Factors Driving the Week’s Mixed Momentum

2026-04-26 09:00:04

Key Events This Week

20 Apr: Stock opens at Rs.1,477.25, down 1.04% amid weak market sentiment

21 Apr: Technical momentum shifts amid bearish signals; valuation shifts to “expensive” rating

22 Apr: Technical momentum shows mild improvement but remains cautious

24 Apr: Stock closes the week at Rs.1,498.00, up 1.27% on the day

Week Open

Rs.1,492.80

<...

Read full news article

Hester Biosciences Ltd is Rated Sell

2026-04-22 10:10:03

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-22 08:01:07

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 0.25%, the stock’s technical indicators present a complex picture, with weekly signals showing mild bullish tendencies contrasting with monthly bearish trends. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity amid mixed signals.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Bearish Signals

2026-04-21 08:01:42

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish stance. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum and trend indicators signal weakening price strength.

Read full news article

Hester Biosciences Ltd: Valuation Shifts Signal Price Attractiveness Amid Sector Challenges

2026-04-21 08:00:21

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions of the stock’s price attractiveness amid fluctuating financial metrics and sector comparisons.

Read full news article

Hester Biosciences Ltd is Rated Sell

2026-04-11 10:10:25

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Markets Rally, But Hester Biosciences Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-01 09:53:00

Despite a broadly positive market environment, Hester Biosciences Ltd has fallen to a fresh 52-week low of Rs 1,250.95 on 1 Apr 2026, marking a 10.27% decline over the past year and underperforming the Sensex by a wide margin.

Read full news article

View All News